These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 3103927)

  • 1. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.
    Cartwright CA; Eckhart W; Simon S; Kaplan PL
    Cell; 1987 Apr; 49(1):83-91. PubMed ID: 3103927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.
    Kmiecik TE; Shalloway D
    Cell; 1987 Apr; 49(1):65-73. PubMed ID: 3103925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src.
    Piwnica-Worms H; Saunders KB; Roberts TM; Smith AE; Cheng SH
    Cell; 1987 Apr; 49(1):75-82. PubMed ID: 3103926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
    Roussel RR; Brodeur SR; Shalloway D; Laudano AP
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. v-src mutations outside the carboxyl-coding region are not sufficient to fully activate transformation by pp60c-src in NIH 3T3 cells.
    Reddy S; Yaciuk P; Kmiecik TE; Coussens PM; Shalloway D
    Mol Cell Biol; 1988 Feb; 8(2):704-12. PubMed ID: 2451122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE
    Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
    Cheng SH; Markland W; Markham AF; Smith AE
    EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.
    Talmage DA; Freund R; Young AT; Dahl J; Dawe CJ; Benjamin TL
    Cell; 1989 Oct; 59(1):55-65. PubMed ID: 2551507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From c-src to v-src, or the case of the missing C terminus.
    Sefton BM; Hunter T
    Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A.
    Yaciuk P; Choi JK; Shalloway D
    Mol Cell Biol; 1989 Jun; 9(6):2453-63. PubMed ID: 2474754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.
    Gorga FR; Riney CE; Benjamin TL
    J Virol; 1990 Jan; 64(1):105-12. PubMed ID: 2152807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus.
    Reynolds AB; Vila J; Lansing TJ; Potts WM; Weber MJ; Parsons JT
    EMBO J; 1987 Aug; 6(8):2359-64. PubMed ID: 2822389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.
    Auger KR; Carpenter CL; Shoelson SE; Piwnica-Worms H; Cantley LC
    J Biol Chem; 1992 Mar; 267(8):5408-15. PubMed ID: 1372000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.
    Cartwright CA; Hutchinson MA; Eckhart W
    Mol Cell Biol; 1985 Oct; 5(10):2647-52. PubMed ID: 2426573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of the pp60v-src carboxyl terminus that are required for transformation.
    Yaciuk P; Shalloway D
    Mol Cell Biol; 1986 Aug; 6(8):2807-19. PubMed ID: 3097514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyr527 is phosphorylated in pp60c-src: implications for regulation.
    Cooper JA; Gould KL; Cartwright CA; Hunter T
    Science; 1986 Mar; 231(4744):1431-4. PubMed ID: 2420005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.
    Bolen JB; Thiele CJ; Israel MA; Yonemoto W; Lipsich LA; Brugge JS
    Cell; 1984 Oct; 38(3):767-77. PubMed ID: 6091900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen.
    Cartwright CA; Kaplan PL; Cooper JA; Hunter T; Eckhart W
    Mol Cell Biol; 1986 May; 6(5):1562-70. PubMed ID: 2431281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.